Randomized controlled trial to investigate the retention time of intravesical instillation therapy with pirarubicin for non-muscule invasive bladder cancer following transurethral resection of bladder tumor.
Latest Information Update: 12 May 2016
At a glance
- Drugs Pirarubicin (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
Most Recent Events
- 12 Dec 2011 New trial record